123 related articles for article (PubMed ID: 38064911)
1. Anti-suicidal effects of IV ketamine in a real-world setting.
O'Brien B; Lee J; Kim S; Nandra GS; Pannu P; Tamman A; Amarneh D; Swann AC; Murphy N; Averill L; Jha M; Mathew SJ
Psychiatry Res; 2024 Jan; 331():115604. PubMed ID: 38064911
[TBL] [Abstract][Full Text] [Related]
2. The Concise Health Risk Tracking - Self-Report (CHRT-SR)-A measure of suicidal risk: Performance in adolescent outpatients.
Nandy K; Rush AJ; Carmody TJ; Kulikova A; Mayes TL; Emslie G; Trivedi MH
Int J Methods Psychiatr Res; 2023 Jun; 32(2):e1944. PubMed ID: 36217566
[TBL] [Abstract][Full Text] [Related]
3. Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality.
Mayes TL; Kennard BD; Killian M; Carmody T; Grannemann BD; Rush AJ; Jha MK; Hughes J; Emslie GJ; Trivedi MH
J Affect Disord; 2018 Aug; 235():45-51. PubMed ID: 29649710
[TBL] [Abstract][Full Text] [Related]
4. A clinical measure of suicidal ideation, suicidal behavior, and associated symptoms in bipolar disorder: Psychometric properties of the Concise Health Risk Tracking Self-Report (CHRT-SR).
Ostacher MJ; Nierenberg AA; Rabideau D; Reilly-Harrington NA; Sylvia LG; Gold AK; Shesler LW; Ketter TA; Bowden CL; Calabrese JR; Friedman ES; Iosifescu DV; Thase ME; Leon AC; Trivedi MH
J Psychiatr Res; 2015 Dec; 71():126-33. PubMed ID: 26476489
[TBL] [Abstract][Full Text] [Related]
5. Psychometric evaluation of the 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR
Nandy K; Rush AJ; Slater H; Mayes TL; Minhajuddin A; Jha M; Blader JC; Brown R; Emslie G; Fuselier MN; Garza C; Gushanas K; Kennard B; Storch EA; Wakefield SM; Trivedi MH
J Affect Disord; 2023 May; 329():548-556. PubMed ID: 36806661
[TBL] [Abstract][Full Text] [Related]
6. Predicting future suicidal events in adolescents using the Concise Health Risk Tracking Self-Report (CHRT-SR).
Mayes TL; Killian M; Rush AJ; Emslie GJ; Carmody T; Kennard BD; Jha MK; King J; Hughes JL; Trivedi MH
J Psychiatr Res; 2020 Jul; 126():19-25. PubMed ID: 32413596
[TBL] [Abstract][Full Text] [Related]
7. Concise Health Risk Tracking scale: a brief self-report and clinician rating of suicidal risk.
Trivedi MH; Wisniewski SR; Morris DW; Fava M; Gollan JK; Warden D; Nierenberg AA; Gaynes BN; Husain MM; Luther JF; Zisook S; Rush AJ
J Clin Psychiatry; 2011 Jun; 72(6):757-64. PubMed ID: 21733476
[TBL] [Abstract][Full Text] [Related]
8. The Concise Health Risk Tracking Self-Report (CHRT-SR) assessment of suicidality in depressed outpatients: A psychometric evaluation.
De La Garza N; Rush AJ; Killian MO; Grannemann BD; Carmody TJ; Trivedi MH
Depress Anxiety; 2019 Apr; 36(4):313-320. PubMed ID: 30370613
[TBL] [Abstract][Full Text] [Related]
9. A longitudinal investigation of the Concise Health Risk Tracking Self-Report (CHRT-SR) in suicidal patients during and after hospitalization.
Villegas AC; DuBois CM; Celano CM; Beale EE; Mastromauro CA; Stewart JG; Auerbach RP; Huffman JC; Hoeppner BB
Psychiatry Res; 2018 Apr; 262():558-565. PubMed ID: 28954699
[TBL] [Abstract][Full Text] [Related]
10. A tool to predict suicidal ideation and behavior in bipolar disorder: The Concise Health Risk Tracking Self-Report.
Reilly-Harrington NA; Shelton RC; Kamali M; Rabideau DJ; Shesler LW; Trivedi MH; McElroy SL; Sylvia LG; Bowden CL; Ketter TA; Calabrese JR; Thase ME; Bobo WV; Deckersbach T; Tohen M; McInnis MG; Kocsis JH; Gold AK; Singh V; Finkelstein DM; Kinrys G; Nierenberg AA
J Affect Disord; 2016 Mar; 192():212-8. PubMed ID: 26748736
[TBL] [Abstract][Full Text] [Related]
11. Replication of distinct trajectories of antidepressant response to intravenous ketamine.
O'Brien B; Lee J; Kim S; Nandra GS; Pannu P; Swann AC; Murphy N; Tamman AJF; Amarneh D; Lijffijt M; Averill LA; Mathew SJ
J Affect Disord; 2023 Jan; 321():140-146. PubMed ID: 36302492
[TBL] [Abstract][Full Text] [Related]
12. A psychometric evaluation of the Concise Health Risk Tracking Self-Report (CHRT-SR)- a measure of suicidality-in patients with stimulant use disorder.
Sanchez K; Killian MO; Mayes TL; Greer TL; Trombello JM; Lindblad R; Grannemann BD; Carmody TJ; Rush AJ; Walker R; Trivedi MH
J Psychiatr Res; 2018 Jul; 102():65-71. PubMed ID: 29626753
[TBL] [Abstract][Full Text] [Related]
13. Effects of ketamine on explicit and implicit suicidal cognition: a randomized controlled trial in treatment-resistant depression.
Price RB; Iosifescu DV; Murrough JW; Chang LC; Al Jurdi RK; Iqbal SZ; Soleimani L; Charney DS; Foulkes AL; Mathew SJ
Depress Anxiety; 2014 Apr; 31(4):335-43. PubMed ID: 24668760
[TBL] [Abstract][Full Text] [Related]
14. A Pilot Study of Ketamine Infusion after Suicide Attempt: New Frontiers in Treating Acute Suicidality in a Real-World Medical Setting.
Shivanekar S; Gopalan P; Pizon A; Spotts C; Cruz N; Lightfoot M; Rohac R; Baumeister A; Griffo A; Panny B; Kucherer S; Israel A; Rengasamy M; Price R
Int J Environ Res Public Health; 2022 Oct; 19(21):. PubMed ID: 36360672
[TBL] [Abstract][Full Text] [Related]
15. The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients.
Trombello JM; Killian MO; Grannemann BD; Rush AJ; Mayes TL; Parsey RV; McInnis M; Jha MK; Ali A; McGrath PJ; Adams P; Oquendo MA; Weissman MM; Carmody TJ; Trivedi MH
J Psychopharmacol; 2019 Feb; 33(2):185-193. PubMed ID: 30652941
[TBL] [Abstract][Full Text] [Related]
16. Rapid and Sustained Reductions in Current Suicidal Ideation Following Repeated Doses of Intravenous Ketamine: Secondary Analysis of an Open-Label Study.
Ionescu DF; Swee MB; Pavone KJ; Taylor N; Akeju O; Baer L; Nyer M; Cassano P; Mischoulon D; Alpert JE; Brown EN; Nock MK; Fava M; Cusin C
J Clin Psychiatry; 2016 Jun; 77(6):e719-25. PubMed ID: 27232360
[TBL] [Abstract][Full Text] [Related]
17. Predicting suicidal events: A comparison of the Concise Health Risk Tracking Self-Report (CHRT-SR) and the Columbia Suicide Severity Rating Scale (C-SSRS).
Mayes TL; Carmody T; Rush AJ; Nandy K; Emslie GJ; Kennard BD; Forbes K; Jha MK; Hughes JL; Heerschap JK; Trivedi MH
Psychiatry Res; 2023 Aug; 326():115306. PubMed ID: 37364504
[TBL] [Abstract][Full Text] [Related]
18. Ketamine for Rapid Reduction of Suicidal Thoughts in Major Depression: A Midazolam-Controlled Randomized Clinical Trial.
Grunebaum MF; Galfalvy HC; Choo TH; Keilp JG; Moitra VK; Parris MS; Marver JE; Burke AK; Milak MS; Sublette ME; Oquendo MA; Mann JJ
Am J Psychiatry; 2018 Apr; 175(4):327-335. PubMed ID: 29202655
[TBL] [Abstract][Full Text] [Related]
19. The 9-item Concise Health Risk Tracking - Self-Report (CHRT-SR
Nandy K; Rush AJ; Carmody TJ; Mayes TL; Trivedi MH
Front Psychiatry; 2023; 14():1014766. PubMed ID: 36865066
[TBL] [Abstract][Full Text] [Related]
20. Suicide Has Many Faces, So Does Ketamine: a Narrative Review on Ketamine's Antisuicidal Actions.
Lengvenyte A; Olié E; Courtet P
Curr Psychiatry Rep; 2019 Dec; 21(12):132. PubMed ID: 31797066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
